Roche Holding AG (WBO:ROGP) Dividends Received


WBO:ROGP Roche Holding AG WBO:ROGP
51 GF Score
Price €360.00
GF Value €287.90
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

WBO:ROGP
51GF Score
Roche Holding AG WBO:ROGP
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (WBO:ROGP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of €360.00 is trading 25% above its estimated GF Value™ of €287.90. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for WBO:ROGP:

  • Dividends Received:
  • GF Value™: €287.90 vs. price of €360.00 (25% above fair value)
  • GF Score™: 51/100 with 7 warning signs

No single metric tells the full story. See the WBO:ROGP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
51GF Score

Get the complete analysis for WBO:ROGP

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€360.00
Price
€287.90
GF Value